Rankings
▼
Calendar
BIIB Q1 2016 Earnings — Biogen Inc. Revenue & Financial Results | Market Cap Arena
BIIB
Biogen Inc.
$28B
Q1 2016 Earnings
Healthcare
Drug Manufacturers - General
Income Statement
Revenue
$2.7B
Gross Profit
$2.4B
88.5% margin
Operating Income
$1.4B
50.6% margin
Net Income
$971M
35.6% margin
EPS (Diluted)
$4.43
Cash Flow
Operating Cash Flow
$963M
Free Cash Flow
$837M
Stock-Based Comp.
$45M
Balance Sheet
Total Assets
$20.7B
Total Liabilities
$10.3B
Stockholders' Equity
$10.3B
Cash & Equivalents
$1.1B
← FY 2016
All Quarters
Q2 2016 →